These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35777974)

  • 21. Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study.
    Sun Y; Wang Y; Mao L; Wen J; Bai W
    Medicine (Baltimore); 2018 Aug; 97(31):e11457. PubMed ID: 30075511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of FIGO PALM-COEIN Classification of the Underlying Causes of Abnormal Uterine Bleeding and Clinicopathological Correlation of Patients Undergoing Hysterectomy in a Tertiary Care Referral Center of Western Rajasthan.
    Gothwal M; Saini A; Singh P; Yadav G; Elhence P; Shekhar S; Samriya N
    Niger Med J; 2022; 63(2):140-146. PubMed ID: 38803698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.
    Munro MG; Critchley HOD; Fraser IS;
    Int J Gynaecol Obstet; 2018 Dec; 143(3):393-408. PubMed ID: 30198563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and management of abnormal uterine bleeding.
    Achanna KS; Nanda J
    Med J Malaysia; 2022 May; 77(3):374-383. PubMed ID: 35638495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of transvaginal color doppler indices to predict malignancy in abnormal uterine bleeding according to PALM-COEIN classification.
    Bayram F; Kender Erturk N; Ozhan E; Ustunyurt E
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):101988. PubMed ID: 33197625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of menstrual bleeding disorders.
    Munro MG
    Rev Endocr Metab Disord; 2012 Dec; 13(4):225-34. PubMed ID: 22851041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Management of Formerly Called "Dysfunctional Uterine Bleeding" According to PALM-COEIN FIGO Classification and the New Guidelines.
    Khrouf M; Terras K
    J Obstet Gynaecol India; 2014 Dec; 64(6):388-93. PubMed ID: 25489140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal uterine bleeding.
    Whitaker L; Critchley HO
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():54-65. PubMed ID: 26803558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas.
    Lonky NM; Chiu V; Portugal C; Estrada EL; Chang J; Fischer H; Vora JB; Harrison LI; Peng L; Munro MG
    PLoS One; 2023; 18(12):e0294925. PubMed ID: 38079406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years.
    Munro MG; Critchley HO; Fraser IS;
    Fertil Steril; 2011 Jun; 95(7):2204-8, 2208.e1-3. PubMed ID: 21496802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal uterine bleeding unrelated to structural uterine abnormalities: management in the perimenopausal period.
    Sabbioni L; Zanetti I; Orlandini C; Petraglia F; Luisi S
    Minerva Ginecol; 2017 Feb; 69(1):75-83. PubMed ID: 27284943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.
    Kriplani A; Srivastava A; Kulshrestha V; Kachhawa G; Agarwal N; Bhatla N; Hari S
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1744-1752. PubMed ID: 27647770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers in abnormal uterine bleeding†.
    Chodankar R; Critchley HOD
    Biol Reprod; 2019 Dec; 101(6):1155-1166. PubMed ID: 30388215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Text mining in a literature review of abnormal uterine bleeding according to the FIGO classification.
    Ono M; Hiraike O; Kitahara Y; Maekawa R; Ota I; Yoshino O; Takai Y; Iwase A;
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1827-1837. PubMed ID: 37170675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of pre-, peri-, and post-menopausal abnormal uterine bleeding: When to perform endometrial sampling?
    Papakonstantinou E; Adonakis G
    Int J Gynaecol Obstet; 2022 Aug; 158(2):252-259. PubMed ID: 34669187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levonorgestrel-releasing intrauterine device to treat abnormal uterine bleeding; not one treatment option fits all.
    Atak Z; Rahımlı Ocakoğlu S; Ocakoğlu G
    J Turk Ger Gynecol Assoc; 2023 Dec; 24(4):246-251. PubMed ID: 38054416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal uterine bleeding.
    Cheong Y; Cameron IT; Critchley HOD
    Br Med Bull; 2017 Sep; 123(1):103-114. PubMed ID: 28910998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in understanding and managing adenomyosis.
    Vannuccini S; Petraglia F
    F1000Res; 2019; 8():. PubMed ID: 30918629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal Uterine Bleeding in Premenopausal Women.
    Wouk N; Helton M
    Am Fam Physician; 2019 Apr; 99(7):435-443. PubMed ID: 30932448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal Uterine Bleeding.
    Khafaga A; Goldstein SR
    Obstet Gynecol Clin North Am; 2019 Dec; 46(4):595-605. PubMed ID: 31677744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.